While Balfaxar met the primary endpoint of hemostatic efficacy in a Phase III study and was non-inferior to the comparator, Kcentra, fatal and non-fatal arterial and venous thromboembolic complications were observed in clinical trials and post-marketing studies, and healthcare providers are advised to monitor patients for signs of thromboembolic events
Mixed Agonist/Antagonist and Partial Agonist Opioid Analgesics The concomitant use of opioids with other opioid analgesics, such as butorphanol, nalbuphine, pentazocine, may reduce the analgesic effect of hydrocodone bitartrate and acetaminophen tablets and/or precipitate withdrawal symptoms
Dysgeusia often alters perception of carbonated drinks because carbonic-anhydrase inhibition changes oral pH
Consequently, the ability to produce stable, non-oxidized L-Glutathione is a key differentiator among manufacturers
WES was also performed on plasma obtained prior to death from 4 patients (Supplementary Fig